<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">
Log In

SmartTRAK Life Sciences News and Analysis Blog

2 min read

Skin Substitutes Get WISeR – Will it Impact the Market?

7/22/25 10:44 AM

WISeR Skin Substitutes Bowling copySmartTRAK reviews CMS’ new WISeR model and its potential impact on the US Skin Substitutes Market.

 A new initiative launched by the Centers for Medicare & Medicaid Services (CMS)’s Innovation Center, which develops payment and service delivery model pilot programs, could impact the Skin Substitutes Market in several states in 2026 and beyond. Other models to come out of the Innovation Center are: Comprehensive Care of Joint Replacement Model and the Maryland Total Cost of Care Model. The newest model, the WISeR Model, short for Wasteful and Inappropriate Service Reduction, leverages AI technology along with human clinical review to streamline prior authorization processes for certain product categories.
 
The WISer Model hopes to use technology to root out wasteful services with limited clinical evidence of effectiveness. It targets many different product categories that CMS determined have a higher risk of waste, fraud and abuse. One such category is skin and tissue substitutes.
 

In this comprehensive article, SmartTRAK provides an overview of the WISeR Model and its potential market impact on skin substitutes.

Click the button below to download and read the complete article "Skin Substitutes Get WISeR – Will it Impact the Market?" by Jay Merkel, SmartTRAK Sr Analyst, Wound.Get the Article

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

Topics: Wound Care Skin Substitute/CTP

Jay Merkel
Written by Jay Merkel

Senior Analyst - 20+ years’ commercial experience in the medical device and technology industries including senior and executive roles at both start up and large organizations such as Integra Life Sciences, BD, Olympus Inc. and B. Braun Medical.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles

SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services.

Contact Us

info@smarttrak.com

3943 Irvine Blvd. #150
Irvine, CA 92602

Sign up for the blog Newsletter

© BioMedGPS, LLC. All rights reserved.